Skin Cancer Affects 1 in 5 Americans by Age 70

Skin cancer is the most common cancer, and melanoma is one of the deadliest cancers. The key to successfully treating this disease begins with promptly detecting it. Ask today about DermaSensor™. The first real-time, non-invasive skin cancer evaluation device for all three common skin cancers.

Find a Physician today with 
a DermaSensor device near you!

Loading...

SKIN CANCER

is the most common form of cancer

Have you noticed any lesions like these?

Basal Cell Carcinoma

Usually open sore-like, red patches or shiny bumps

Squamous Cell Carcinoma

Usually bumpy or sore-like skin cancers that are on the surface layers of the skin

Melanoma

Commonly a darkly pigmented skin cancer spot that can occur anywhere on the body

Highly Atypical Nevus

Irregularly shaped and more than one color. May develop into melanoma

If you see any lesions like these on yourself or a loved one, talk to your doctor today!

Find a Physician Near You

Watch to learn more about DermaSensor!

First FDA-cleared automated device designed to detect all three common skin cancers
Immediate results in seconds
Harmless and non-invasive
DermaSensor can be used on all skin tones

DermaSensor can be used on all skin tones

In an FDA pivotal study, DermaSensor was tested and validated on more than 1,000 patients across all Fitzpatrick skin types.* The Fitzpatrick scale is a skin tone classification system used to assess skin color and response to ultraviolet (UV) exposure.

Skin Type I
Skin Type II
Skin Type III
Skin Type IV
Skin Type V
Skin Type VI

What are doctors saying about DermaSensor?

“Google said it was cancer but let’s assess your lesion now with our new age AI assisted skin cancer screening device to provide real time objective results”

- Alliance Medical Clinic in Anthem, AZ

"In sunny Miami, skin cancer is a real concern. I’m excited to use a new non-invasive, FDA-cleared, AI-powered device to improve detection accuracy and provide peace of mind for high-risk patients."​

- Dr. Eduardo Alacron, Family Medicine​

“The DermaSensor device will be a great service to provide to my patients who are concerned about skin lesions, and an invaluable tool to help me decide how to manage their care.”

- Dr. Dean Hildahl in Naples, Florida

“The DermaSensor device will be a great service to provide to my patients who are concerned about skin."

- Dr. Dean Hildahl in Naples, Florida

"By integrating this technology into our resident training program, the Florida State University Family Medicine Residency Program at BayCare Health Systems aims to empower its future physicians with enhanced skin cancer detection skills."

- Dr. Nathan Falk, Founding Program Director at Family Medicine Residency at DayCare Health System

"I am excited to offer this new technology for skin cancer detection to the patients in my primary care office. The 4-6 month wait time to get in with a dermatologist in our are creates much anxiety."

- Dr. Josephine Lake, Lake Internal Medicine

Learn more about DermaSensor

The first real-time, non-invasive skin cancer evaluation device for all three common skin cancers.